Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

South Korea

Busan Paik Hospital, Inje University, Busan

Pusan National University Hospital, Busan

Yeungnam University Medical Center, Daegu

Kim's Eye Hospital, Seoul

Seoul National University Hospital, Seoul